Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
Cryoport files to sell $100M of convertible senior notes due 2025  18:55
05/19/20
05/19
18:55
05/19/20
18:55
CYRX

Cryoport

$26.14 /

+1.68 (+6.87%)

 
ShowHide Related Items >><<
CYRX Cryoport
$26.14 /

+1.68 (+6.87%)

CYRX Cryoport
$26.14 /

+1.68 (+6.87%)

05/11/20 Roth Capital
Cryoport price target raised to $30 from $25 at Roth Capital
01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
01/07/20 Stephens
Cryoport initiated with an Overweight at Stephens
07/01/19 Needham
Cryoport reinstated with a Buy at Needham
CYRX Cryoport
$26.14 /

+1.68 (+6.87%)

CYRX Cryoport
$26.14 /

+1.68 (+6.87%)

Recommendations
Cryoport price target raised to $30 from $25 at Roth Capital » 09:04
05/11/20
05/11
09:04
05/11/20
09:04
CYRX

Cryoport

$20.72 /

+0.23 (+1.12%)

Roth Capital analyst…

Roth Capital analyst Richard Baldry raised the firm's price target on Cryoport to $30 from $25 and keeps a Buy rating on the shares. The analyst notes that the company's Q1 revenues set a record despite late quarter COVID-19 pressures. With spending still ramping to support product development and growth, its adjusted EBITDA loss of ($1.7M) was well below recent results, he contends. However, Baldry still sees a strong pipeline of potential client commercial launches and increasing clinical trial volumes as simmering growth drivers.

ShowHide Related Items >><<
CYRX Cryoport
$20.72 /

+0.23 (+1.12%)

01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
01/07/20 Stephens
Cryoport initiated with an Overweight at Stephens
07/01/19 Needham
Cryoport reinstated with a Buy at Needham
Earnings
Cryoport reports Q1 EPS (11c), consensus (5c) » 17:26
05/07/20
05/07
17:26
05/07/20
17:26
CYRX

Cryoport

$20.49 /

+0.16 (+0.79%)

Reports Q1 revenue $9.8M,…

Reports Q1 revenue $9.8M, consensus $9.76M. CEO Jerrell Shelton stated, "We are very pleased to report strong clinical trial growth for the quarter as we added a net total of 29 clinical trials, bringing the total number of clinical trials supported by Cryoport to a record 465. As providers of mission-critical logistics solutions to the healthcare industry, we are actively monitoring the spread of COVID-19 and continue to operate our Global Logistics Center Network with minimal impact on our ability to conduct day-to-day operations for our life sciences clients. While a meaningful number of the clinical trials we support have been suspended temporarily, none of these trials, to our knowledge, have been terminated as a result of COVID-19. These suspensions did impact our clinical trial revenue in late First Quarter and that impact continues into Q2".

ShowHide Related Items >><<
CYRX Cryoport
$20.49 /

+0.16 (+0.79%)

01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
01/07/20 Stephens
Cryoport initiated with an Overweight at Stephens
07/01/19 Needham
Cryoport reinstated with a Buy at Needham
Over a month ago
Conference/Events
Cryoport management to meet virtually with B.Riley FBR » 04:55
04/02/20
04/02
04:55
04/02/20
04:55
CYRX

Cryoport

$15.85 /

-1.17 (-6.87%)

Virtual Meetings to be…

Virtual Meetings to be held April 1-2 hosted by B. Riley FBR.

ShowHide Related Items >><<
CYRX Cryoport
$15.85 /

-1.17 (-6.87%)

01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
01/07/20 Stephens
Cryoport initiated with an Overweight at Stephens
07/01/19 Needham
Cryoport reinstated with a Buy at Needham
Conference/Events
Cryoport management to meet virtually with B.Riley FBR » 04:55
04/01/20
04/01
04:55
04/01/20
04:55
CYRX

Cryoport

$17.02 /

+0.04 (+0.24%)

Virtual Meetings to be…

Virtual Meetings to be held April 1-2 hosted by B. Riley FBR.

ShowHide Related Items >><<
CYRX Cryoport
$17.02 /

+0.04 (+0.24%)

01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
01/07/20 Stephens
Cryoport initiated with an Overweight at Stephens
07/01/19 Needham
Cryoport reinstated with a Buy at Needham
Conference/Events
Cryoport management to meet virtually with B.Riley FBR » 10:29
03/26/20
03/26
10:29
03/26/20
10:29
CYRX

Cryoport

$15.68 /

+0.21 (+1.36%)

Virtual Meetings to be…

Virtual Meetings to be held April 1-2 hosted by B. Riley FBR.

ShowHide Related Items >><<
CYRX Cryoport
$15.68 /

+0.21 (+1.36%)

01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
01/07/20 Stephens
Cryoport initiated with an Overweight at Stephens
07/01/19 Needham
Cryoport reinstated with a Buy at Needham
Earnings
Cryoport reports Q4 EPS (5c), consensus (7c) » 16:08
03/05/20
03/05
16:08
03/05/20
16:08
CYRX

Cryoport

$17.32 /

-0.56 (-3.13%)

Reports Q4 revenue $9.2M,…

Reports Q4 revenue $9.2M, consensus $9.34M. Reports $94.3M in cash, cash equivalents and short-term investments as of December 31, 2019, compared with $47.3M as of December 31, 2018.

ShowHide Related Items >><<
CYRX Cryoport
$17.32 /

-0.56 (-3.13%)

01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
01/07/20 Stephens
Cryoport initiated with an Overweight at Stephens
07/01/19 Needham
Cryoport reinstated with a Buy at Needham
Over a quarter ago
Hot Stocks
Cryoport and Inception Fertility enter multi-year agreement » 08:36
02/26/20
02/26
08:36
02/26/20
08:36
CYRX

Cryoport

$16.96 /

-1.23 (-6.76%)

Cryoport announced a…

Cryoport announced a multi-year agreement with Inception Fertility, a Houston-based company which operates The Prelude Network and MyEggBank, one of the largest frozen donor egg banks in North America. Under the terms of this partnership, The Prelude Network and MyEggBank will utilize Cryoport's temperature-controlled supply chain solutions across its entire clinical network. The Prelude Network and MyEggBank will utilize Cryoport's supply chain management and informatics platform to process both domestic and international shipments of eggs, embryos and throughout its global network. International shipments are expected to rapidly increase as Cryoport's solutions will expand Inception Fertility's processing bandwidth.

ShowHide Related Items >><<
CYRX Cryoport
$16.96 /

-1.23 (-6.76%)

01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
01/07/20 Stephens
Cryoport initiated with an Overweight at Stephens
07/01/19 Needham
Cryoport reinstated with a Buy at Needham
Conference/Events
Regenerative Medicine Foundation to hold a summit » 04:55
01/24/20
01/24
04:55
01/24/20
04:55
ABC

AmerisourceBergen

$91.17 /

-0.92 (-1.00%)

, ATHX

Athersys

$1.34 /

+0.045 (+3.49%)

, BLUE

Bluebird Bio

$89.74 /

-4.05 (-4.32%)

, CLBS

Caladrius

$3.01 /

+0.09 (+3.08%)

, CYRX

Cryoport

$19.74 /

-0.07 (-0.35%)

, GLW

Corning

$29.55 /

-0.11 (-0.37%)

, HEMA

HemaCare

$0.00 /

+ (+0.00%)

, IOVA

Iovance Biotherapeutics

$22.70 /

-0.49 (-2.11%)

, IQV

Iqvia

$160.87 /

+0.38 (+0.24%)

, LZAGY

Lonza

$0.00 /

+ (+0.00%)

, MBIO

Mustang Bio

$4.20 /

+0.035 (+0.84%)

, MCK

McKesson

$155.12 /

-0.605 (-0.39%)

, NVO

Novo Nordisk

$61.61 /

+0.27 (+0.44%)

, NWBO

Northwest Biotherapeutics

$0.00 /

+ (+0.00%)

, SYNH

Syneos Health

$64.73 /

+0.15 (+0.23%)

, TECH

Bio-Techne

$218.68 /

-0.53 (-0.24%)

, THMO

ThermoGenesis

$4.70 /

-0.19 (-3.89%)

, TMO

Thermo Fisher

$335.31 /

-4.665 (-1.37%)

15th Annual World Stem…

15th Annual World Stem Cell Summit will be held in Miami on January 21-24.

ShowHide Related Items >><<
ABC AmerisourceBergen
$91.17 /

-0.92 (-1.00%)

10/16/19 Jefferies
Drug distributor settlement would make stocks 'ownable again,' says Jefferies
10/16/19 Jefferies
Drug distributor settlement would make stocks 'ownable again,' says Jefferies
10/16/19 Barclays
Barclays ups McKesson target on probability of favorable settlement
09/11/19 Deutsche Bank
AmerisourceBergen initiated with a Hold at Deutsche Bank
ATHX Athersys
$1.34 /

+0.045 (+3.49%)

08/26/19 Dawson James
Athersys initiated with a Buy at Dawson James
BLUE Bluebird Bio
$89.74 /

-4.05 (-4.32%)

12/18/19 JPMorgan
BioMarin, Vertex among JPMorgan's top Biotech picks for 2020
12/13/19
Fly Intel: Top five analyst upgrades
12/13/19 Oppenheimer
Bluebird Bio upgraded following ASH updates at Oppenheimer
12/12/19 Oppenheimer
Bluebird Bio upgraded to Outperform from Perform at Oppenheimer
CLBS Caladrius
$3.01 /

+0.09 (+3.08%)

01/24/19 H.C. Wainwright
Caladrius an 'intriguing opportunity' near cash levels, says H.C. Wainwright
CYRX Cryoport
$19.74 /

-0.07 (-0.35%)

01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
01/07/20 Stephens
Cryoport initiated with an Overweight at Stephens
07/01/19 Needham
Cryoport reinstated with a Buy at Needham
GLW Corning
$29.55 /

-0.11 (-0.37%)

01/08/20 Morgan Stanley
Morgan Stanley stepping away from Corning 'for now,' downgrades to Equal Weight
01/08/20 Morgan Stanley
Corning downgraded to Equal Weight from Overweight at Morgan Stanley
10/30/19 Deutsche Bank
Corning downgraded to Hold from Buy at Deutsche Bank
10/03/19 H.C. Wainwright
Cesca Therapeutics price target raised to $7.50 from $6.50 at H.C. Wainwright
HEMA HemaCare
$0.00 /

+ (+0.00%)

IOVA Iovance Biotherapeutics
$22.70 /

-0.49 (-2.11%)

01/14/20 Piper Sandler
Iovance Biotherapeutics quietly provided 'positive' update, says Piper Sandler
12/18/19 JMP Securities
Iovance Biotherapeutics initiated with an Outperform at JMP Securities
11/21/19 Wells Fargo
Iovance financing concerns misplaced, says Well Fargo
11/10/19 Piper Sandler
Piper Jaffray reiterates Overweight on Iovance after SITC update
IQV Iqvia
$160.87 /

+0.38 (+0.24%)

01/13/20 Morgan Stanley
Veeva upgraded to Overweight following underperformance at Morgan Stanley
01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Iqvia initiated with an Overweight at Wells Fargo
01/06/20 Citi
Iqvia initiated with a Buy at Citi
LZAGY Lonza
$0.00 /

+ (+0.00%)

01/31/19 BofA
Lonza downgraded to Neutral from Buy at BofA/Merrill
MBIO Mustang Bio
$4.20 /

+0.035 (+0.84%)

01/09/20 Cantor Fitzgerald
Mustang Bio named top pick for 2020 at Cantor Fitzgerald
11/20/19 Cantor Fitzgerald
Mustang Bio assumed with an Overweight at Cantor Fitzgerald
08/13/19 H.C. Wainwright
Mustang Bio initiated with a Buy at H.C. Wainwright
06/21/19 Cantor Fitzgerald
Cantor starts Mustang Bio with Overweight rating, $7 price target
MCK McKesson
$155.12 /

-0.605 (-0.39%)

01/10/20
Fly Intel: Top five analyst upgrades
01/10/20 Guggenheim
Change Healthcare price target raised to $20 from $17 at Guggenheim
01/10/20 Morgan Stanley
Morgan Stanley upgrades McKesson, names Centene, Anthem top Healthcare picks
01/10/20 Morgan Stanley
McKesson upgraded to Overweight from Equal Weight at Morgan Stanley
NVO Novo Nordisk
$61.61 /

+0.27 (+0.44%)

01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral on continued insulin headwinds at Guggenheim
01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
11/22/19 Pareto
Novo Nordisk downgraded to Hold from Buy at Pareto
11/19/19 SunTrust
Dicerna price target raised to $28 from $24 at SunTrust
NWBO Northwest Biotherapeutics
$0.00 /

+ (+0.00%)

SYNH Syneos Health
$64.73 /

+0.15 (+0.23%)

01/16/20 Baird
Syneos Health price target raised to $74 from $62 at Baird
01/16/20 KeyBanc
Syneos Health price target raised to $71 from $65 at KeyBanc
01/06/20 Citi
Citi calls Syneos Health top CRO pick, initiates at Buy
01/06/20 Citi
Syneos Health initiated with a Buy at Citi
TECH Bio-Techne
$218.68 /

-0.53 (-0.24%)

01/08/20 Stephens
Bio-Techne resumed with an Overweight at Stephens
01/07/20 Wells Fargo
Bio-Techne initiated with an Equal Weight at Wells Fargo
01/06/20 Citi
Bio-Techne initiated with a Neutral at Citi
11/14/19 Stifel
Bio-Techne initiated with a Buy at Stifel
THMO ThermoGenesis
$4.70 /

-0.19 (-3.89%)

TMO Thermo Fisher
$335.31 /

-4.665 (-1.37%)

01/22/20
Fly Intel: Top five analyst initiations
01/22/20 Credit Suisse
Thermo Fisher initiated with a Neutral at Credit Suisse
01/09/20 JPMorgan
Danaher, Thermo named JPMorgan's top 2020 picks in Life Science Tools
01/07/20 Wells Fargo
Thermo Fisher initiated with an Equal Weight at Wells Fargo
Conference/Events
Regenerative Medicine Foundation to hold a summit » 04:55
01/23/20
01/23
04:55
01/23/20
04:55
ABC

AmerisourceBergen

$92.09 /

+0.85 (+0.93%)

, ATHX

Athersys

$1.29 /

+0.01 (+0.78%)

, BLUE

Bluebird Bio

$93.79 /

-2.11 (-2.20%)

, CLBS

Caladrius

$2.92 /

+0.02 (+0.69%)

, CYRX

Cryoport

$19.81 /

+0.4 (+2.06%)

, GLW

Corning

$29.66 /

-0.06 (-0.20%)

, HEMA

HemaCare

$0.00 /

+ (+0.00%)

, IOVA

Iovance Biotherapeutics

$23.19 /

-0.46 (-1.95%)

, IQV

Iqvia

$160.49 /

-0.33 (-0.21%)

, LZAGY

Lonza

$0.00 /

+ (+0.00%)

, MBIO

Mustang Bio

$4.16 /

-0.08 (-1.89%)

, MCK

McKesson

$155.72 /

+0.45 (+0.29%)

, NVO

Novo Nordisk

$61.34 /

+0.19 (+0.31%)

, NWBO

Northwest Biotherapeutics

$0.00 /

+ (+0.00%)

, SYNH

Syneos Health

$64.58 /

+0.71 (+1.11%)

, TECH

Bio-Techne

$219.21 /

-2.32 (-1.05%)

, THMO

ThermoGenesis

$4.89 /

+0.13 (+2.73%)

, TMO

Thermo Fisher

$339.97 /

+2.59 (+0.77%)

15th Annual World Stem…

15th Annual World Stem Cell Summit will be held in Miami on January 21-24.

ShowHide Related Items >><<
ABC AmerisourceBergen
$92.09 /

+0.85 (+0.93%)

10/16/19 Jefferies
Drug distributor settlement would make stocks 'ownable again,' says Jefferies
10/16/19 Jefferies
Drug distributor settlement would make stocks 'ownable again,' says Jefferies
10/16/19 Barclays
Barclays ups McKesson target on probability of favorable settlement
09/11/19 Deutsche Bank
AmerisourceBergen initiated with a Hold at Deutsche Bank
ATHX Athersys
$1.29 /

+0.01 (+0.78%)

08/26/19 Dawson James
Athersys initiated with a Buy at Dawson James
BLUE Bluebird Bio
$93.79 /

-2.11 (-2.20%)

12/18/19 JPMorgan
BioMarin, Vertex among JPMorgan's top Biotech picks for 2020
12/13/19
Fly Intel: Top five analyst upgrades
12/13/19 Oppenheimer
Bluebird Bio upgraded following ASH updates at Oppenheimer
12/12/19 Oppenheimer
Bluebird Bio upgraded to Outperform from Perform at Oppenheimer
CLBS Caladrius
$2.92 /

+0.02 (+0.69%)

01/24/19 H.C. Wainwright
Caladrius an 'intriguing opportunity' near cash levels, says H.C. Wainwright
CYRX Cryoport
$19.81 /

+0.4 (+2.06%)

01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
01/07/20 Stephens
Cryoport initiated with an Overweight at Stephens
07/01/19 Needham
Cryoport reinstated with a Buy at Needham
GLW Corning
$29.66 /

-0.06 (-0.20%)

01/08/20 Morgan Stanley
Morgan Stanley stepping away from Corning 'for now,' downgrades to Equal Weight
01/08/20 Morgan Stanley
Corning downgraded to Equal Weight from Overweight at Morgan Stanley
10/30/19 Deutsche Bank
Corning downgraded to Hold from Buy at Deutsche Bank
10/03/19 H.C. Wainwright
Cesca Therapeutics price target raised to $7.50 from $6.50 at H.C. Wainwright
HEMA HemaCare
$0.00 /

+ (+0.00%)

IOVA Iovance Biotherapeutics
$23.19 /

-0.46 (-1.95%)

01/14/20 Piper Sandler
Iovance Biotherapeutics quietly provided 'positive' update, says Piper Sandler
12/18/19 JMP Securities
Iovance Biotherapeutics initiated with an Outperform at JMP Securities
11/21/19 Wells Fargo
Iovance financing concerns misplaced, says Well Fargo
11/10/19 Piper Sandler
Piper Jaffray reiterates Overweight on Iovance after SITC update
IQV Iqvia
$160.49 /

-0.33 (-0.21%)

01/13/20 Morgan Stanley
Veeva upgraded to Overweight following underperformance at Morgan Stanley
01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Iqvia initiated with an Overweight at Wells Fargo
01/06/20 Citi
Iqvia initiated with a Buy at Citi
LZAGY Lonza
$0.00 /

+ (+0.00%)

01/31/19 BofA
Lonza downgraded to Neutral from Buy at BofA/Merrill
MBIO Mustang Bio
$4.16 /

-0.08 (-1.89%)

01/09/20 Cantor Fitzgerald
Mustang Bio named top pick for 2020 at Cantor Fitzgerald
11/20/19 Cantor Fitzgerald
Mustang Bio assumed with an Overweight at Cantor Fitzgerald
08/13/19 H.C. Wainwright
Mustang Bio initiated with a Buy at H.C. Wainwright
06/21/19 Cantor Fitzgerald
Cantor starts Mustang Bio with Overweight rating, $7 price target
MCK McKesson
$155.72 /

+0.45 (+0.29%)

01/10/20
Fly Intel: Top five analyst upgrades
01/10/20 Guggenheim
Change Healthcare price target raised to $20 from $17 at Guggenheim
01/10/20 Morgan Stanley
Morgan Stanley upgrades McKesson, names Centene, Anthem top Healthcare picks
01/10/20 Morgan Stanley
McKesson upgraded to Overweight from Equal Weight at Morgan Stanley
NVO Novo Nordisk
$61.34 /

+0.19 (+0.31%)

01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral on continued insulin headwinds at Guggenheim
01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
11/22/19 Pareto
Novo Nordisk downgraded to Hold from Buy at Pareto
11/19/19 SunTrust
Dicerna price target raised to $28 from $24 at SunTrust
NWBO Northwest Biotherapeutics
$0.00 /

+ (+0.00%)

SYNH Syneos Health
$64.58 /

+0.71 (+1.11%)

01/16/20 Baird
Syneos Health price target raised to $74 from $62 at Baird
01/16/20 KeyBanc
Syneos Health price target raised to $71 from $65 at KeyBanc
01/06/20 Citi
Citi calls Syneos Health top CRO pick, initiates at Buy
01/06/20 Citi
Syneos Health initiated with a Buy at Citi
TECH Bio-Techne
$219.21 /

-2.32 (-1.05%)

01/08/20 Stephens
Bio-Techne resumed with an Overweight at Stephens
01/07/20 Wells Fargo
Bio-Techne initiated with an Equal Weight at Wells Fargo
01/06/20 Citi
Bio-Techne initiated with a Neutral at Citi
11/14/19 Stifel
Bio-Techne initiated with a Buy at Stifel
THMO ThermoGenesis
$4.89 /

+0.13 (+2.73%)

TMO Thermo Fisher
$339.97 /

+2.59 (+0.77%)

01/22/20
Fly Intel: Top five analyst initiations
01/22/20 Credit Suisse
Thermo Fisher initiated with a Neutral at Credit Suisse
01/09/20 JPMorgan
Danaher, Thermo named JPMorgan's top 2020 picks in Life Science Tools
01/07/20 Wells Fargo
Thermo Fisher initiated with an Equal Weight at Wells Fargo

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.